Trial Profile
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Cyclophosphamide; Doxorubicin liposomal; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 20 Jan 2017 New trial record